Skip to main content

Allograft Transplant cancer Registry

  • Chapter
Immune Deficiency and Cancer

Abstract

Advances in our understanding of cancer derive from the recent discovery that immune deficiency is associated with an increased frequency of malignancies, particularly lymphomas. This increase has been observed both in naturally occurring diseases (23,47) and in conditions produced by iatrogenic depression of immunity (76–86). A prime example is the immunosuppressed state induced in organ transplant recipients. In 1968, we first drew attention to an increased incidence of neoplasms in this group of patients (76). Since then, we have maintained an informal allograft transplant cancer registry. Physicians from many countries have generously contributed their data. The cases reported up to September 1982 are summarized here.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Allen, D.W. and Cole, P. Viruses and human cancer. N. Engl. J. Med., 286:70, 1972.

    Article  PubMed  CAS  Google Scholar 

  2. Armstrong, M.Y.K., Ruddle, N.H., Lipman, M.B., and Richards, F.F. Tumor induction by immunologically activated murine leukemia virus. J. Exp. Med., 137:1163, 1973.

    Article  PubMed  CAS  Google Scholar 

  3. Bach, F.H. Personal communication, 1981.

    Google Scholar 

  4. Bach, M.L., Engstrom, M.A., Bach, F.H., Etheredge, E.E., and Najarian, J.S. Specific tolerance in human kidney allograft recipients. Cell. Immunol., 3:161, 1972.

    Article  PubMed  CAS  Google Scholar 

  5. Balls, M. and Ruben, L.N. Lymphoid tumors in amphibia: a review. Prog. Exp. Tumor Res., 10:238, 1968.

    Google Scholar 

  6. Bieber, C.P., Hunt, S.A., Schwinn, D.A., Jamieson, S.A., Reitz, B.A., Oyer, P.E., Shumway, N.E., and Stinson, E.B. Complications in long-term survivors of cardiac transplantation. Transplant. Proc., 13:207, 1981.

    PubMed  CAS  Google Scholar 

  7. Burnet, F.M. Immunological surveillance in neoplasia. Transplant. Rev., 7:3, 1971.

    PubMed  CAS  Google Scholar 

  8. Calne, R.Y., Rolles, K., White, J.G., Thiru, S., Evans, D.B., Henderson, R., Hamilton, D.L., Boone, N., McMaster, P., Gibby, O., and Williams, R. Cyclosporin-A in clinical organ grafting. Transplant. Proc, 13:349, 1981.

    PubMed  CAS  Google Scholar 

  9. Caro, W.A. Tumors of the skin. In: S.L. Moschella, D.M. Pillsbury, H.J. Hurley Jr. (eds.), Dermatology. pp. 1323–1406. Philadelphia: W.B. Saunders, Co., 1975.

    Google Scholar 

  10. Coleman, D.V., Gardner, S.D., and Field, A.M. Human Polyomavirus infection in renal allograft recipients. Br. Med. J.3:371 1973.

    Article  PubMed  CAS  Google Scholar 

  11. Cotton, J.R., Sarles, H.E., Remmers, A.R. Jr., Lindley, J.D., Beathard, G.A., Cottom, D.L., Fish, J.C., Townsend, C.M. Jr., and Ritzmann, S.E. The appearance of reticulum cell sarcoma at the site of antilymphocyte globulin injection. Transplantation, 16:154, 1973.

    Article  PubMed  CAS  Google Scholar 

  12. Crawford, D.H., Thomas, J.A., Janossy, G., Sweny, P., Fernando, O.N., Moorhead, J.F., and Thompson, J.H. Epstein-Barr virus nuclear antigen positive lymphoma after Cyclosporin A treatment in patients with renal allograft. Lancet, i:355, 1980.

    Google Scholar 

  13. Crawford, D.H., Sweny, P., Edwards, J.M.B., Janossy, G., and Hoffbrand A.V. Long-term T-cell mediated immunity to Epstein-Barr virus in renal-allograft recipients receiving Cyclosporin A. Lancet, i:10, 1981.

    Article  Google Scholar 

  14. Declerq, E. and Merigan, T.C. Current concept of interferon and interferon production. Ann. Rev. Med., 21:17, 1970.

    Article  Google Scholar 

  15. Dent, P.B., Fish, L.A., White, J.G., and Good, R.A. Chediak-Higashi Syndrome. Observations on the nature of the associated malignancy. Lab Invest., 15:1634, 1966.

    PubMed  CAS  Google Scholar 

  16. Deodhar, S.D., Kuklinca, A.G., Vidt, D.G., Robertson, A.L., and Hazard, J.B. Development of reticulum-cell sarcoma at the site of antilymphocyte globulin injection in a patient with renal transplant. N. Engl. J. Med., 280:1104, 1969.

    Article  PubMed  CAS  Google Scholar 

  17. Editorial: Is phenytoin carcinogenic? Lancet, ii:1071, 1971.

    Google Scholar 

  18. Editorial: Looking at lymphomas. Lancet, ii:306, 1979.

    Google Scholar 

  19. Ehrlich, P. Uber den jetzigen stand der Karzinomforschung. In: The Collected Papers of Paul Ehrlich. Vol. 2, p. 550. London: Pergamon Press, 1957.

    Google Scholar 

  20. Francis, D.M.A. and Shenton, B.K. Blood transfusion and tumour growth: evidence from laboratory animals. (Letter to the Editor). Lancet, ii:871, 1981.

    Article  Google Scholar 

  21. Freeman, C., Berg, J.W., and Cutler, S.J. Occurrence and prognosis of extranodal lymphomas. Cancer, 29:252, 1972.

    Article  PubMed  CAS  Google Scholar 

  22. Furth, J. Conditioned and autonomous neoplasms: a review. Cancer Res., 13:477, 1953.

    PubMed  CAS  Google Scholar 

  23. Gatti, R.A. and Good, R.A. Occurrence of malignancy in immunodeficiency diseases. A literature review. Cancer, 28:89, 1971.

    Article  PubMed  CAS  Google Scholar 

  24. Geis, W.P., Iwatzuki, S., Moinar, Z., Giacchino, J.L., Kerman, R.H., Ing, T.S., and Hano, J.E. Pseudolymphoma in renal allograft recipients. Arch. Surg., 113:461, 1978.

    Article  PubMed  CAS  Google Scholar 

  25. Gershwin, M.E. and Steinberg, A.D. Loss of suppressor function as a cause of lymphoid malignancy. Lancet, ii:1174, 1973.

    Article  Google Scholar 

  26. Giraldo, G., Beth, E., and Hagenau, F. Herpes-type virus particles in tissue culture of Kaposi’s sarcoma from different geographical regions. J. Natl. Cancer Inst., 49:1509, 1972.

    PubMed  CAS  Google Scholar 

  27. Gisser, S.D. Papovavirus and squamous cell carcinoma. Human Pathol., 12:190, 1981.

    Article  CAS  Google Scholar 

  28. Gleichmann, E., Gleichmann, H., Schwartz, R.S., Weinblatt, A., and Armstrong, M.Y.K. Immunologic induction of malignant lymphoma: identification of donor and host tumors in the graft-versus-host model. J. Natl. Cancer Inst., 54:l07. 1975.

    Google Scholar 

  29. Giovanella, B., Nilsson, K., Zech, L., Yim, O., Klein, G., and Stehlin, J.S. Growth of diploid, Epstein-Barr virus-carrying human lymphoblastoid cell lines heterotransplanted into nude mice under immunologically privileged conditions. Int. J. Cancer, 24:103, 1979.

    Article  PubMed  CAS  Google Scholar 

  30. Gossett, T.C., Gale, R.P., Fleischman, H., Austin, G.E., Sparkes, R.S., and Taylor, C.R. Immunoblastic sarcoma in donor cells after bone-marrow transplantation. N. Engl. J. Med., 300:904, 1979.

    Article  PubMed  CAS  Google Scholar 

  31. Gresser, I. Antitumor effects of Interferon. In: F.F. Becker (ed.), Cancer. A Comprehensive Treatise. Vol. 5, pp. 521–571. New York: Plenum Press, 1977.

    Google Scholar 

  32. Grossberg, S.E. The interferons and their inducers: molecular and therapeutic considerations. N. Engl. J. Med., 287:13, 79, 122, 1972.

    Article  PubMed  CAS  Google Scholar 

  33. Gupta, P.K., Pinn, V.M., and Taft, D.D. Cervical dysplasia associated with azathioprine (Imuran) therapy. Acta Cytol., 13:373, 1969.

    PubMed  CAS  Google Scholar 

  34. Hammar, S. and Mennemeyer, R. Lymphomatoid granulomatosis in a renal transplant recipient. Hum. Pathol., 7:111, 1976.

    Article  PubMed  CAS  Google Scholar 

  35. Hanto, D.W., Sakamoto, K., Purtilo, D.T., Simmons, R.L., and Najarian, J.S. The Epstein-Barr virus in the pathogenesis of post-transplant lymphoproliferative disorders. Surgery, 90:204, 1981.

    PubMed  CAS  Google Scholar 

  36. Harris, C.C. The carcinogenicity of anticancer drugs: a hazard in man. Cancer, 37:1014, 1976.

    Article  PubMed  CAS  Google Scholar 

  37. Hattan, D. and Cerilli, G.J. Spontaneous reticulum cell sarcomas developing in C3H/HeJ mice on prolonged immunosuppressive therapy. Transplantation, 11:580, 1971.

    PubMed  CAS  Google Scholar 

  38. Herberman, R.B. and Ortaldo, J.R. Natural killer cells: their role in defenses against disease. Science, 214:24, 1981.

    Article  PubMed  CAS  Google Scholar 

  39. Herman, T.S., Hammond, N., Jones, S.E., Butler, J.J., Byrne, G.E. Jr., and McKelvey, E.M. Involvement of the central nervous system by non-Hodgkin’s lymphoma. The Southwest Oncology Group Experience, Cancer, 43:390, 1979.

    Article  PubMed  CAS  Google Scholar 

  40. Hirsch, M.S., Proffitt, M.R., and Black, P.H. Autoimmunity, oncornaviruses, and lymphomagenesis. Contemp. Topics Immunobiol., 6:209, 1977.

    Article  CAS  Google Scholar 

  41. Hoover, R. and Fraumeni, J.F. Jr. Risk of cancer in renal transplant recipients. Lancet, ii:55, 1973.

    Article  Google Scholar 

  42. Hoover, R. and Fraumeni, J.F. Jr. Cancer risks in renal transplant recipients. Cited by Kinlen, L. (ref. 49), in press.

    Google Scholar 

  43. IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans. Some antineoplastic and immunosuppressive agents. Vol. 26, pp. 33. Lyon. World Health Organization, International Agency for Research on Cancer, 1981.

    Google Scholar 

  44. Ioachira, H.L. The stromal reaction of tumors: an expression of immune surveillance. J. Natl. Cancer Inst., 57:465, 1976.

    Google Scholar 

  45. Jerusalem, C. Relationship between malaria infection (Plasmodium berghei) and malignant lymphoma in mice. Z. Tropenmed. Parasitol., 19:94, 1968.

    PubMed  CAS  Google Scholar 

  46. Kay, S., Frable, W.J., and Hume, D.M. Cervical dysplasia and cancer development in women on immunosuppression therapy for renal homotransplantation. Cancer, 26:1048, 1970.

    Article  PubMed  CAS  Google Scholar 

  47. Kayhoe, D.E., Jacobs, L., Beye, K.K., and McCullough, N.B. Acquired toxoplasmosis: observations on two parasitologically proved cases treated with pyrimethamine and triple sulfonamides. N. Engl. J. Med., 257:1247, 1957.

    Article  PubMed  CAS  Google Scholar 

  48. Kersey, J.H., Spector, B.D. and Good, R.A. Primary immunodeficiency diseases and cancer: the Immunodeficiency-Cancer Registry. Int. J. Cancer, 12:333, 1973.

    Article  PubMed  CAS  Google Scholar 

  49. Kinlen, L.J., Sheil, A.G.R., Peto, J., and Doll, R. Collaborative United Kingdom-Australian study of cancer in patients treated with immunosuppressive drugs. Br. Med. J., 2:1461, 1979.

    Article  PubMed  CAS  Google Scholar 

  50. Kinlen, L. Immunosuppressive therapy and cancer. Cancer Surveys, in press.

    Google Scholar 

  51. Klein, G. Herpes viruses and oncogenesis. Proc. Natl. Acad. Sci. USA, 69:1056, 1972.

    Article  PubMed  CAS  Google Scholar 

  52. Koranda, F.C., Dehmel, E.M., Kahn, G., and Penn, I. Cutaneous complications in immunosuppressed renal horaograft recipients. J. Am. Med. Assoc., 229:419, 1974.

    Article  CAS  Google Scholar 

  53. Koranda, F.C., Loeffler, R.T., Koranda, D.M. and Penn, I. Accelerated induction of skin cancers by ultraviolet radiation in hairless mice treated with immunosuppressive agents. Surg. Forum, 26:l45, 1975.

    Google Scholar 

  54. Krikorian, J.G., Anderson, J.L., Bieber, C.P., Penn, I., and Stinson, E.B. Malignant neoplasms following cardiac transplantation. J. Am. Med. Assoc, 240:639, 1978.

    Article  CAS  Google Scholar 

  55. Krikorian, J.G., Portlock, C.S., Cooney, P., and Rosenberg, S.A. Spontaneous regression of non-Hodgkin’s lymphoma: a report of nine cases. Cancer, 46:2093, 1980.

    Article  PubMed  CAS  Google Scholar 

  56. Kripke, M.L. and Borsos, T. Immune surveillance revisited. J. Natl. Cancer Inst., 51:1393, 1974.

    Google Scholar 

  57. Krueger, G. The significance of immunosuppression and antigenic stimulation in the development of malignant lymphomas. In: E. Grundmann and R. Gross (eds.), The Ambivalence of Cytostatic Therapy, Recent Results in Cancer Research. Vol. 52, pp. 88–95. Berlin: Springer-Verlag, 1975.

    Chapter  Google Scholar 

  58. Kvasnicka, A. Relationship between herpes simplex and lip carcinoma IV. Selected cases. Neoplasma, 12:6l, 1965.

    Google Scholar 

  59. Li, F.P., Willard, D.R., Goodman, R. and Vawter, G. Malignant lymphoma after diphenylhydantoin (Dilantin) therapy. Cancer, 36:1359, 1975.

    Article  PubMed  CAS  Google Scholar 

  60. Lipinski, M., Tursz, T., Kreis, H., Finale, Y., and Amiel, J-L. Disassociation of natural killer cell activity and antibody-dependent cell-mediated cytotoxicity in kidney allograft recipients receiving high-dose immunosuppressive therapy. Transplantation, 29:214, 1980.

    Article  PubMed  CAS  Google Scholar 

  61. Lukes, R.J. and Collins, R.D. Immunologic characterization of human malignant lymphomas. Cancer, 34:l488, 1974.

    Google Scholar 

  62. Lukes, R.J. and Tindle, B.H. Immunobiastic lymphadenopathy: a hyperimmune entity resembling Hodgkin’s disease. N. Engl. J. Med., 292:1, 1975.

    Article  PubMed  CAS  Google Scholar 

  63. Lutzner, M.A. Epidermodysplasia verruciformis. An autosomal recessive disease characterized by viral warts and skin cancer. A model for viral oncogenesis. Bull. Cancer, 65:169, 1978.

    PubMed  CAS  Google Scholar 

  64. Marshall, V. Premalignant and malignant skin tumors in immunosuppressed patients. Transplantation, 17:272, 1974.

    Article  PubMed  CAS  Google Scholar 

  65. Matas, A.J., Simmons, R.L., and Najarian, J.S. Chronic antigenic stimulation, herpes virus infection, and cancer in transplant patients. Lancet, i:1277, 1975.

    Article  Google Scholar 

  66. McDevitt, H.O. Regulation of the immune response by the major histocompatibility system. N. Engl. J. Med., 303:1514, 1980.

    Article  PubMed  CAS  Google Scholar 

  67. Metcalf, D. Induction of reticular tumors in mice by repeated antigenic stimulation. Acta Unio Int. Contra Cancrun, 19:657, 1963.

    CAS  Google Scholar 

  68. Miller, C.T. Isoniazid and cancer risks (Letter to the Editor). J. Am. Med. Assoc., 230: 1254, 1974.

    Article  CAS  Google Scholar 

  69. Miller, D.G. On the nature of susceptibility to cancer. Cancer, 46:1307, 1980.

    Article  PubMed  CAS  Google Scholar 

  70. Möller, G. and Möller, E. The concept of immunological surveillance against neoplasia. Transplant. Rev., 28:3, 1976.

    PubMed  Google Scholar 

  71. Munyon, W., Kraiselburd, E., Davis, D., and Mann, J. Transfer of thymidine kinase to hymidine kinaseless L cells by infection with ultraviolet-irradiated Herpes simplex virus. J. Virol., 7:813, 1971.

    PubMed  CAS  Google Scholar 

  72. Najarian, J.S., Sutherland, D.E.R., Ferguson, R.M., Simmons, R.L., Kersey, J., Mauer, S.M., Slavin, S., and Kim, T.H. Total lymphoid irradiation and kidney transplantation: a clinical experience. Transplant. Proc., 13(1):417, 1981.

    PubMed  CAS  Google Scholar 

  73. Nehlsen, S.L. ATS-mediated immunosuppression and tumor risk. Behring Institute Mitteilungen, Marburg, Behringwerke AG pp. 201–203, 1972.

    Google Scholar 

  74. O’Neill, F.J. and Miles, C.P. Chromosome changes in human cells induced by herpes simplex, Types 1 and 2. Nature, 223:851, 1969.

    Article  PubMed  Google Scholar 

  75. Opelz, G. Transfusions and malignancy. (Letter to the Editor) Lancet, ii:1057, 1981.

    Article  Google Scholar 

  76. Oyer, P.E., Stinson, E.B., Jamieson, S.W., Hunt, S., Reitz, B.A., Bieber, C.P., Schroeder, J.S., Billingham, M., and Shumway, N.E. One year experience with Cyclosporin A in clinical heart transplantation. Heart Trans., in press.

    Google Scholar 

  77. Penn, I., Hammond, W., Brettschneider, L., and Starzl, T.E. Malignant lymphomas in transplantation patients. Tranplant. Proc, 1:106, 1969.

    CAS  Google Scholar 

  78. Penn, I. Malignant tumors in organ transplant recipients. New York: Springer-Verlag, 1970.

    Google Scholar 

  79. Penn, I. Tumors arising in organ transplant recipients. In: G. Klein and S. Weinhouse (eds.), Advances in Cancer Research. Vol. 28, pp. 31–61. New York: Academic Press, 1978.

    Google Scholar 

  80. Penn, I. Host origin of lymphomas in organ transplant recipients. Transplantation, 27:214, 1979.

    Article  PubMed  CAS  Google Scholar 

  81. Penn, I. Tumors in allograft recipients (Letter to the Editor). N. Engl. J. Med., 30:385, 1979.

    Google Scholar 

  82. Penn, I. Kaposi’s sarcoma in organ transplant recipients: report of 20 cases. Transplantation, 27:8, 1979.

    Article  PubMed  CAS  Google Scholar 

  83. Penn, I. Immunosuppression and skin cancer. Clin. Plastic Surg., 7:361, 1980.

    CAS  Google Scholar 

  84. Penn, I. Malignant lymphomas in organ transplant recipients. Transplant Proc, 13:736, 1981.

    PubMed  CAS  Google Scholar 

  85. Penn, I. The price of immunotherapy. Cur. Prob. Surg., 18(11):682, 1981.

    Google Scholar 

  86. Penn, I. The occurrence of cancer in immune deficiencies. Cur. Prob. Cancer, 6(10):1, 1982.

    Article  CAS  Google Scholar 

  87. Penn, I. Malignancies following the use of Cyclosporin A in man. Cancer Surveys, in press.

    Google Scholar 

  88. Porreco, R., Penn, I., Droegemueller, W., Greer, B. and Makowski, E. Gynecologic malignancies in immunosuppressed organ homograft recipients. Obstet. Gynec., 45:359, 1975.

    PubMed  CAS  Google Scholar 

  89. Powell, L.C. Jr. Condyloma acuminatum: recent advances in development, carcinogenesis and treatment. Clin. Obstet. Gynecol., 21:1061, 1978.

    Article  PubMed  Google Scholar 

  90. Prehn, R.T. Do tumors grow because of the immune response of the host? Transplant. Rev., 28:34, 1976.

    PubMed  CAS  Google Scholar 

  91. Rapp, F. Question: do herpes viruses cause cancer? Answer: of course they do. J. Natl. Cancer Inst. (Editorial), 50:825, 1973.

    CAS  Google Scholar 

  92. Reddy, S., Pellettiere, E., Saxena, V., and Hendrickson, F.R. Extranodal non-Hodgkin’s lymphoma. Cancer, 46:1925, 1980.

    Article  PubMed  CAS  Google Scholar 

  93. Reitz, B.A., Bieber, C.P., and Pennock, J.L. Cyclosporin A and lymphoma in non-human primates. In: R.Y. Calne and D.J.G. White (eds.), Proceedings International Symposium on Cyclosporin A. Elsevier North Holland Biomedical Press, in press.

    Google Scholar 

  94. Roder, J. and Duwe, A. The beige mutation in the mouse selectively impairs natural killer cell function. Nature (London), 278:451, 1979.

    Article  CAS  Google Scholar 

  95. Roder, J.C., Haliotis, T., Klein, M., Korec, S., Jett, J.R., Ortaldo, J., Herberman, R.B., Katz, R., and Fauci, A.S. A new immunodeficiency disorder in humans involving NK cells. Nature (London), 284:553, 1980.

    Article  CAS  Google Scholar 

  96. Schramm, G. Development of severe cervical dysplasia under treatment with azathioprine (Imuran). Acta Cytol., 14:507, 1975.

    Google Scholar 

  97. Schwartz, R.S. Another look at immunologic surveillance. N. Engl. J. Med., 293:181, 1975.

    Article  PubMed  CAS  Google Scholar 

  98. Shah, K.H., Lewis, M.G., Jenson, A.B., Kurman, R.J., and Lancaster, W.D. Papillomavirus and cervical dysplasia. Lancet, ii:1190, 1980.

    Article  Google Scholar 

  99. Sheil, A.G.R., Mahoney, J.F., Horvath, J.S., Johnson, J.R., Tiller, D.J., May, J., and Stewart, J.H. Cancer and survival after cadaveric donor renal transplantation. Transplant. Proc., 11:1052, 1979.

    PubMed  CAS  Google Scholar 

  100. Sheil, A.G.R., Mahoney, J.F., Horvath, J.S., Johnson, J.R., Tiller, D.J., Stewart, J.H., and May, J. Cancer following successful cadaveric renal transplantation. Tranplant. Proc., 13: 1981.

    Google Scholar 

  101. Shulman, H.M., Sullivan, K.M., Weiden, P.L., McDonald, G.B., Striker, G.E., Sale, G.E., Hackman, R., Tsoi, M., Storb, R., and Thomas, E.D. Graft versus host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Amer. J. Med., 69:204, 1980.

    Article  PubMed  CAS  Google Scholar 

  102. Southam, C.M., Tanaka, S., Arata, T., Simkovic, D., Miura, M., and Petropolos, S.F. Enhancement of responses to chemical carcinogens by nononcogenic viruses and antimetabolites. Prog. Exp. Tumor. Res. (Basel), 11:194, 1969.

    CAS  Google Scholar 

  103. Special report. Epidemiologic aspects of the current outbreak of Kaposi’s sarcoma and opportunistic infections. N. Engl. J. Med., 306:248, 1932.

    Google Scholar 

  104. Spencer, E.S. and Andersen, H.K. Clinically evident, nonterminal infections with herpes viruses and the wart virus in immunosuppressed renal allograft recipients. Br. Med. J., 3:251, 1970.

    Article  PubMed  CAS  Google Scholar 

  105. Stevens, D.A. Immunosuppression and virus infections. Transplant. Proc., 5:1259, 1973.

    PubMed  CAS  Google Scholar 

  106. Stutman, O. Immunodepression and malignancy. Adv. Cancer Res., 22:261, 1975.

    Article  PubMed  CAS  Google Scholar 

  107. Stutman, O. Immunological surveillance. In: Origins of Human Cancer. pp. 729–750. Cold Spring Harbor Laboratory, 1977.

    Google Scholar 

  108. Suciu-Foca, N., Dumitrescu, V., Lazar, C. and Nachtigal, M. Host and tumor modifications associated with serial heterotransplantation of tumors through immunologically tolerant animals. Cancer Res., 30:1681, 1970.

    PubMed  CAS  Google Scholar 

  109. Taylor, C.R. Classification of lymphoma. New “thinking” on old thoughts. Arch. Pathol. Lab. Med., 102:549, 1978.

    PubMed  CAS  Google Scholar 

  110. Templeton, A.C. Kaposi’s sarcoma. In: R. Andrade, S.L. Gumport, G.L. Popkin, and T.D. Rees (eds.), Cancer of the Skin. Biology-Diagnosis-Management. pp. 1183–1225. Philadelphia: W.B. Saunders Co., 1976.

    Google Scholar 

  111. Thomas, L. Discussion of Medawar, P.B. Reactions to homologous tissue antigens in relation to hypersensitivity. In: H.S. Lawrence (ed.), Cellular and Humoral Aspects of the Hypersensitive States. pp. 529–532. New York: Paul Hoeber, 1959.

    Google Scholar 

  112. Walford, R.L. and Hildemann, W.H. Life span and lymphomaincidence of mice injected at birth with spleen cells across a weak histocompatibility locus. Amer. J. Pathol., 47:713, 1965.

    CAS  Google Scholar 

  113. Warner, T.F.C.S. and O’Loughlin, S. Kaposi’s sarcoma: a byproduct of tumor rejection. Lancet, ii:687, 1975.

    Article  Google Scholar 

  114. Weintraub, J. and Warnke, R.A. Lymphoma in cardia allograft recipients. Clinical and histological features and immunological phenotype. Transplantation, 33:347, 1982.

    Article  PubMed  CAS  Google Scholar 

  115. Wentz, W.B., Reagan, J.W., Heggie, A.D., Fu, Y-S., and Anthony, D.D. Induction of uterine cancer with inactivated herpes simplex virus, 1 and 2. Cancer, 48:1783, 1981.

    Article  PubMed  CAS  Google Scholar 

  116. Wyburn-Mason, R. Malignant change arising in tissues affected by herpes. Br. Med. J., 2:106, 1955.

    Article  Google Scholar 

  117. Wyburn-Mason, R. Malignant change following herpes simplex. Brit. Med. J., 2:6l5, 1957.

    Google Scholar 

  118. Zarling, J.M., Robins, H.I., Raich, P.C., Bach, F.H., and Bach, M.L. Generation of cytotoxic T lymphocytes to autologous human leukemia cells by sensitization to pooled allogeneic normal cells. Nature, 274:269, 1978.

    Article  PubMed  CAS  Google Scholar 

  119. Zarling, J.M. and Bach, F.H. Continuous culture of T cells cytotoxic for autologous human leukemia cells. Nature, 280:685, 1979.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Plenum Publishing Corporation

About this chapter

Cite this chapter

Penn, I. (1984). Allograft Transplant cancer Registry. In: Purtilo, D.T. (eds) Immune Deficiency and Cancer. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4760-6_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-4760-6_14

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-4762-0

  • Online ISBN: 978-1-4684-4760-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics